Press Releases

TSRL, Inc. Rebrands as TSRLabs Ahead of Its Next Chapter of Growth

New name, visual identity and website position Ann Arbor preclinical CRO for its next phase of scientific growth

Psychedelic Medicines Approach a Historic FDA Approval Milestone with Safety Under Scrutiny

The FDA's historic psychedelic hearing highlighted a critical question: how can psychedelic medicines become accessible without compromising patient safety? As developers move closer to potential approvals, regulators must balance clinical evidence, professional oversight, workforce training, geographic access and long-term safety.

FDA Approves AstraZeneca’s Etcamah, Bringing ctDNA-Guided Treatment to Breast Cancer

AstraZeneca’s Etcamah has received FDA accelerated approval for ctDNA-guided treatment in HR-positive, HER2-negative breast cancer with ESR1 mutations. The decision could establish an earlier treatment-switch strategy based on molecular changes before cancer becomes visible on scans.

FibroFind appoints leading transplant physician Professor Andrew Fisher as Chief Medical Officer

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Targeting a signal released by dormant cancer cells could help overcome resistance to immunotherapy and improve cellular therapies for pancreatic cancer.

Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform

Qinecsa has been selected as technology partner for AfriVigilance, the African Medicines Agency’s new continent-wide medicines safety surveillance platform, with implementation already underway.

Panther Life Sciences Appoints Mounir Hanana as Chief Executive Officer

Hanana brings 25 years of experience scaling global technology, consumer, and manufacturing businesses at Amazon and Procter & Gamble. Founder Carlos Bhola continues as Executive Chairman, leading strategy, product vision and corporate development. Hanana joins as Panther begins commercializing its SmartPatch™ platform, starting with cosmetics and medical aesthetics and expanding to therapeutic applications.

Peer-Reviewed Study Published in MDPI’s AI Journal Shows NetraAI Uncovers Clinical Trial Signals Missed by Conventional AI and Foundation Models

The study evaluated NetraAI across clinical datasets in schizophrenia, major depressive disorder and pancreatic cancer, benchmarking the technology against eight industry-standard predictive models. Results show NetraAI's biological and clinical signatures successfully boosted the accuracy of all eight evaluated algorithms across every single dataset tested.

UT-led study finds COVID-19 can awaken hidden viruses throughout the body

Researchers say dormant viruses many people harbor can reactivate during COVID-19 and may be linked to long COVID symptoms.

Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil

Biocon has secured a 10-year PDP allocation for pertuzumab in Brazil through a partnership with Bahiafarma and Bionovis, covering around 70% of the country’s public-sector demand. The agreement combines long-term supply with phased local production, supporting affordable cancer treatment access and strengthening Brazil’s domestic biopharmaceutical capabilities.

CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company

Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending CluePoints' science-first approach from RBQM into clinical data review. The partner will join CluePoints live at SCDM 2026 to celebrate the launch.

Yourgene Health Insight DPYD Assay Achieves IVDR Accreditation

Comprehensive pharmacogenetic testing solution aligned with latest clinical guidance to support informed chemotherapy treatment decisions

MIB Agents Now Accepting Letters of Intent for 2027 OutSmarting Osteosarcoma Research Grants

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, families, medical professionals, researchers and industry partners, is accepting letters of intent (LOI) starting on Wednesday, September 9, for its annual OutSmarting Osteosarcoma research grant program.

Inceptua Acquires SupplyRx to Enhance Pharmacy Services for Clinical Trials

Inceptua Group today announced the acquisition of SupplyRx to enhance pharmacy services for clinical trials.

Integrion Automation Builds on Its Medical Device Capabilities to Support Validated, Traceable Production

Integrion Automation provides validated, traceable automation solutions for medical device manufacturers, helping improve quality, compliance, and flexibility in regulated production environments. Its GAMP 5-based approach, validation services, advanced inspection and assembly technologies, and lifecycle support help manufacturers reduce risk while maintaining audit-ready operations.

Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform

Integrated DNA Technologies (IDT) and Ansa Biotechnologies expand partnership, making it easier for researchers to access longer, more complex DNA.

Inceptua Group Selected to Manage TikoMed’s Named Patient Program for Investigational Therapy ILB® in Amyotrophic Lateral Sclerosis (ALS)

Inceptua and TikoMed have announced the launch of a Named Patient Program for TikoMed’s investigational drug, ILB®, for eligible patients with Amyotrophic Lateral Sclerosis.

Symbiosis strengthens commercial team with appointment of Jay Chima

Allegheny Health Network and The START Center for Cancer Research Announce Strategic Collaboration to Expand Patient Access to Early-Phase Cancer Trials

New START site to be established within AHN Cancer Center will integrate novel oncology research therapies closer to patients across Western Pennsylvania.

Prescient completes integration of Uptake and Dolon under single global brand